New Delhi: Drug firm Cadila Healthcare has received overwhelming approval from stakeholders for scheme of arrangement between the company and Zydus Healthcare Ltd.
Almost 100% shareholders have approved “the scheme of arrangement between Cadila Healthcare Ltd and Zydus Healthcare Ltd and their respective shareholders and creditors,” Cadila Healthcare said in a BSE filing on Saturday.
The voting results were the outcome of a National Company Law Tribunal (NCLT) convened meeting of the shareholders of the company held on 30 March 2017, it added.
Pharma firm Cadila Healthcare is a listed entity of the Zydus Group.
